Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

Carmustine for Injection, USP - SFDA Drug Approval Details

Approvals/SFDA/Carmustine for Injection, USP

Authorized

NCE

Carmustine for Injection, USP

Unknown🇸🇦 Saudi Food and Drug Authority

Approval Date: N/A
Approval ID: 08a7d3c5cc3430dd
Company: Unknown
Type: NCE

Approval Details

Approval Id: 08a7d3c5cc3430dd
Drug Approval Sfda Name: Carmustine for Injection, USP
Trade Name: Carmustine for Injection, USP
Generic Name: CARMUSTINE
Register Number: 2303210622
Register Year: 2021
Drug Type: NCE
Route Of Administration: Intravenous use
Package Type: Vial
Package Size: 1
Legal Status: Prescription
Authorization Status: Valid
Marketing Status: Marketed
Product Control: Uncontrolled
Storage Conditions: Store in a refrigerator (2°C – 8°C), do not freeze
Shelf Life: 36 Months
Distribution Site: Hospital
Description Code: 7000001400-100-100000073860
Price: 3267

Active Ingredients

Authorized

Quick Info

Agency

SFDA

Country

🇸🇦

Approval ID

08a7d3c5cc3430dd

Type

NCE

Back to SFDA Approvals